Document details

Hemoglobinopathies in newborns from Salvador, Bahia, Northeast Brazil


Description

p. 292-298

Submitted by Ana Valéria de Jesus Moura (anavaleria_131@hotmail.com) on 2011-09-27T13:15:03Z No. of bitstreams: 1 32.pdf: 74190 bytes, checksum: 08432f5e87d18caf5654bad4e8b92f82 (MD5)

Made available in DSpace on 2011-09-27T13:15:03Z (GMT). No. of bitstreams: 1 32.pdf: 74190 bytes, checksum: 08432f5e87d18caf5654bad4e8b92f82 (MD5) Previous issue date: 2005

Hemoglobinopathies are hereditary disorders of the hemoglobin molecule with a high prevalence worldwide. Brazil has a prevalence of 0.1 to 0.3% of newborns with sickle cell anemia and 20.0 to 25.0% of heterozygous α2 thalassemia among African Brazilians. In the present study, we investigated the presence of variant emoglobins and α2 3.7 Kb and α2 4.2 Kb thalassemia in newborns from Salvador, Bahia, Brazil. Samples of umbilical cord blood from a total of 590 newborns were analyzed, of which 57 (9.8%) were FAS; 36 (6.5%) FAC; one (0.2%) SF; and five (0.9%) FSC. One hundred fourteen (22.2%) newborns had α2 3.7 Kb thalassemia, of whom 101 (19.7%) were heterozygous and 13 (2.5%) homozygous, showing statistical significance for hematological data between newborns with normal α genes and α2 3.7 Kb thalassemia carriers. The α2 4.2 Kb thalassemia was not found. Frequencies found in the present study confirm that hemoglobinopathies are a public health problem in Brazil, emphasizing the need for neonatal screening and genetic counseling programs.

Document Type Journal article
Language English
facebook logo  linkedin logo  twitter logo 
mendeley logo

Related documents

No related documents